Zoetis | ZTS - Current Assets

Stock Price
115.62
Daily Change
0.16 0.14%
Monthly
-7.92%
Yearly
-28.30%
Q1 Forecast
112.13

Zoetis reported $6.77B in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
AbbVie USD 29.06B 523M Dec/2025
Align Technology USD 2.62B 82.47M Dec/2025
Bayer EUR 32.91B 30M Dec/2025
Bristol-Myers Squibb USD 35.63B 2.41B Sep/2025
Charles River Laboratories USD 1.45B 85.06M Dec/2025
Coherus Biosciences USD 206.71M 254.25M Dec/2025
Dentsply International USD 2.02B 49M Dec/2025
Eli Lilly USD 55.63B 6.44B Dec/2025
Henry Schein USD 4.46B 69M Dec/2025
Idexx Laboratories USD 1.41B 63.23M Dec/2025
Illumina USD 3.29B 493M Dec/2025
IQVIA Holdings USD 6.25B 270M Dec/2025
J&J USD 55.62B 1.01B Dec/2025
Laboratory Of America USD 4.02B 58.3M Dec/2025
Merck USD 47.56B 10.49B Sep/2025
Neogen USD 574.58M 50.52M Sep/2025
Pacira USD 547.97M 14.78M Dec/2025
Perrigo USD 2.8B 81.8M Dec/2025
Pfizer USD 46.92B 3.22B Sep/2025
Phibro Animal Health USD 862.18M 26.39M Dec/2025
Quest Diagnostics USD 2.38B 29M Dec/2025
Sanofi EUR 30.95B 3.09B Dec/2025
Sanofi EUR 30.95B 8.99B Dec/2025
Zoetis USD 6.77B 185M Dec/2025